Biotech

All Articles

Praxis epilepsy medication reduces confiscations in period 2 litigation

.Praxis Accuracy Medicines has racked up another midphase win in epilepsy this year, with its own sa...

Three directors resign as Dyne articles mixed information for DMD applicant

.After getting away a scientific hold numerous years back, Dyne Therapeutics has actually revealed b...

Arrowhead fires off phase 3 records in rare metabolic disease ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give in front of a prospective face-off al...

Pfizer, Valneva reveal lyme illness go efficient for 2nd enhancer

.Pfizer as well as Valneva might have about pair of additional years to hang around before they help...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Allow's study a conversation along with Ayla Ellison, Fierce Biotech Editor-in-Chief as well as Mic...

New data show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the period 3 trial for its aspect XIa inhibitor asundexian late in 2015 after the d...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stockpile as fund shows intent to mold its own development

.Galapagos is actually coming under added tension from entrepreneurs. Having built a 9.9% concern in...

Cell- centered Sana gathers 1st CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings an...

Allist pays off Jacobio $21M, landing part in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has actually bought on its own a starring role in China's KRAS mark...